Arbutus Biopharma Corp Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Arbutus Biopharma Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Arbutus Biopharma Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 189M shares, a 13.1% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 189M +21.8M +13.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 180M +15.1M +9.12% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 170M +12.4M +7.88% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 168M +15M +9.81% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 167M +18.1M +12.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 165M +16.4M +11% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 157M +12.5M +8.6% Dec 31, 2022 10-K 2024-03-05
Q3 2022 153M +42.4M +38.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 149M +51.1M +52.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 149M +52.5M +54.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 145M +55.3M +61.7% Dec 31, 2021 10-K 2023-03-02
Q3 2021 110M +25.6M +30.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 97.7M +26.4M +37.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 96.2M +39.4M +69.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 89.7M +24.9M +38.4% Dec 31, 2020 10-K 2022-03-03
Q3 2020 84.6M +27.8M +48.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 71.3M +14.4M +25.3% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 56.9M +594K +1.06% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 64.8M +9.26M +16.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 56.9M +1.38M +2.48% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 56.9M +1.52M +2.76% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 56.3M +1.17M +2.12% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 55.5M +458K +0.83% Dec 31, 2018 10-K 2020-03-05
Q3 2018 55.5M +420K +0.76% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 55.3M +298K +0.54% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 55.1M +62.6K +0.11% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 55.1M +219K +0.4% Dec 31, 2017 10-K 2019-03-07
Q3 2017 55.1M +210K +0.38% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 55M +230K +0.42% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 55M +399K +0.73% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 54.8M +271K +0.5% Dec 31, 2016 10-K 2018-03-16
Q3 2016 54.8M +272K +0.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 54.8M +493K +0.91% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 54.6M +530K +0.98% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 54.6M +32.1M +143% Dec 31, 2015 10-K 2017-03-22
Q3 2015 54.6M +32.3M +145% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 54.3M +32.2M +146% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 54.1M +32.1M +146% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 22.4M +3.39M +17.8% Dec 31, 2014 10-K 2016-03-09
Q3 2014 22.3M Sep 30, 2014 10-Q 2014-11-07
Q2 2014 22.1M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 22M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 19M +4.74M +33.2% Dec 31, 2013 10-K 2015-03-13
Q4 2012 14.3M +2.16M +17.8% Dec 31, 2012 10-K 2014-03-28
Q4 2011 12.1M +1.81M +17.5% Dec 31, 2011 20-F 2013-03-27
Q4 2010 10.3M Dec 31, 2010 20-F 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.